Walvax Biotechnology Co., Ltd. (Walvax)

Founded in 2001, Walvax Biotechnology Co., Ltd. (Walvax) is a leading vaccine producer, engaged in research and development, manufacturing and distribution of safe and efficacious quality vaccines.

Headquartered in China’s southwestern city Kunming, Yunnan Province, Walvax went public via IPO in 2010 (300142.SZ) and started business expansion from traditional vaccines to innovative vaccines.

With the vision of dedicating to be the pride domestically and the pioneer globally in the vaccine industry, Walvax produces efficacious, quality, innovative and affordable products to protect people from the world’s deadliest diseases, for the purpose of helping everyone live a healthy life.